TrialAnnals of the rheumatic diseases2020

Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction.

Robert Bm Landewé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.